Literature DB >> 32394305

Epigenetic dynamics in cancer stem cell dormancy.

Alejandra I Ferrer1, Jonathan R Trinidad2, Oleta Sandiford1, Jean-Pierre Etchegaray3, Pranela Rameshwar4.   

Abstract

Cancer remains one of the most challenging diseases despite significant advances of early diagnosis and therapeutic treatments. Cancerous tumors are composed of various cell types including cancer stem cells capable of self-renewal, proliferation, differentiation, and invasion of distal tumor sites. Most notably, these cells can enter a dormant cellular state that is resistant to conventional therapies. Thereby, cancer stem cells have the intrinsic potential for tumor initiation, tumor growth, metastasis, and tumor relapse after therapy. Both genetic and epigenetic alterations are attributed to the formation of multiple tumor types. This review is focused on how epigenetic dynamics involving DNA methylation and DNA oxidations are implicated in breast cancer and glioblastoma multiforme. The emergence and progression of these cancer types rely on cancer stem cells with the capacity to enter quiescence also known as a dormant cellular state, which dictates the distinct tumorigenic aggressiveness between breast cancer and glioblastomas.

Entities:  

Keywords:  Bone marrow; Breast cancer; Cancer stem cells; Dormancy; Epigenetics; Glioblastoma multiforme; TET

Mesh:

Substances:

Year:  2020        PMID: 32394305     DOI: 10.1007/s10555-020-09882-x

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  153 in total

1.  A precarious balance: pluripotency factors as lineage specifiers.

Authors:  Kyle M Loh; Bing Lim
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

2.  Pluripotency factors in embryonic stem cells regulate differentiation into germ layers.

Authors:  Matt Thomson; Siyuan John Liu; Ling-Nan Zou; Zack Smith; Alexander Meissner; Sharad Ramanathan
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

3.  Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.

Authors:  Hye Rim Han; Soon A Park; Stephen Ahn; Sin-Soo Jeun; Chung Heon Ryu
Journal:  Anticancer Res       Date:  2019-12       Impact factor: 2.480

Review 4.  Epigenetic reprogramming in cancer.

Authors:  Mario L Suvà; Nicolo Riggi; Bradley E Bernstein
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

Review 5.  Glioblastoma and other malignant gliomas: a clinical review.

Authors:  Antonio Omuro; Lisa M DeAngelis
Journal:  JAMA       Date:  2013-11-06       Impact factor: 56.272

Review 6.  Cancer micrometastases.

Authors:  Klaus Pantel; Catherine Alix-Panabières; Sabine Riethdorf
Journal:  Nat Rev Clin Oncol       Date:  2009-06       Impact factor: 66.675

7.  An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.

Authors:  Ittai Ben-Porath; Matthew W Thomson; Vincent J Carey; Ruping Ge; George W Bell; Aviv Regev; Robert A Weinberg
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

Review 8.  Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis.

Authors:  Emanuely Silva Chrun; Filipe Modolo; Filipe Ivan Daniel
Journal:  Pathol Res Pract       Date:  2017-06-28       Impact factor: 3.250

Review 9.  Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.

Authors:  U D Kahlert; S M Mooney; M Natsumeda; H-J Steiger; J Maciaczyk
Journal:  Int J Cancer       Date:  2016-07-20       Impact factor: 7.396

10.  Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy.

Authors:  Shyam A Patel; Shakti H Ramkissoon; Margarette Bryan; Lillian F Pliner; Gabriela Dontu; Prem S Patel; Sohrab Amiri; Sharon R Pine; Pranela Rameshwar
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

View more
  11 in total

1.  miR-26a-5p Suppresses Wnt/β-Catenin Signaling Pathway by Inhibiting DNMT3A-Mediated SFRP1 Methylation and Inhibits Cancer Stem Cell-Like Properties of NSCLC.

Authors:  Jie Yu; Zhe Ge; Shunqiong Chen; Shaoying Li; Xin Zhang; Jie Hu; Wei Guo; Yan Wang
Journal:  Dis Markers       Date:  2022-07-11       Impact factor: 3.464

2.  Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway.

Authors:  Lin Lu; Zhiqiang Zha; Peiling Zhang; Peipei Wang; Xia Liu; Xisheng Fang; Chengyin Weng; Baoxiu Li; Haibo Mao; Lina Wang; Mingmei Guan; Yong Wu; Zhixiang Xu; Zhongqiu Liu; Guolong Liu
Journal:  Oncogenesis       Date:  2022-04-29       Impact factor: 6.524

Review 3.  The role of RNA processing and regulation in metastatic dormancy.

Authors:  Kimberly A Parker; Nathaniel J Robinson; William P Schiemann
Journal:  Semin Cancer Biol       Date:  2021-03-26       Impact factor: 15.707

Review 4.  Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies.

Authors:  Subhasree Kumar; Edward A Gonzalez; Pranela Rameshwar; Jean-Pierre Etchegaray
Journal:  Cancers (Basel)       Date:  2020-12-05       Impact factor: 6.639

Review 5.  The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.

Authors:  Kangchen Chen; Chenzhi Zhang; Sunbin Ling; Rongli Wei; Jianguo Wang; Xiao Xu
Journal:  Cell Death Dis       Date:  2021-09-04       Impact factor: 8.469

Review 6.  Redox Control of the Dormant Cancer Cell Life Cycle.

Authors:  Bowen Li; Yichun Huang; Hui Ming; Edouard C Nice; Rongrong Xuan; Canhua Huang
Journal:  Cells       Date:  2021-10-09       Impact factor: 6.600

Review 7.  Bone Marrow-Derived Cells in Endometrial Cancer Pathogenesis: Insights from Breast Cancer.

Authors:  Alejandra I Ferrer; Ella Einstein; Sara S Morelli
Journal:  Cells       Date:  2022-02-17       Impact factor: 6.600

8.  Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.

Authors:  Jiongyu Chen; Yixuan Zhuang; Ping Wang; Jinfeng Ning; Wei Liu; Yiteng Huang; Xueqiong Lin; Lin Peng; Donghong Zhang
Journal:  Cell Death Dis       Date:  2022-03-07       Impact factor: 8.469

Review 9.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

Review 10.  CD36 and CD97 in Pancreatic Cancer versus Other Malignancies.

Authors:  Cristiana Tanase; Ancuta-Augustina Gheorghisan-Galateanu; Ionela Daniela Popescu; Simona Mihai; Elena Codrici; Radu Albulescu; Mihail Eugen Hinescu
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.